{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:27:43Z","timestamp":1782098863721,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11551-9","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:47:25Z","timestamp":1758804445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Seroprevalence of SARS-CoV-2 antibodies in Ethiopia: findings from the 2022 national population-based survey (second round)"],"prefix":"10.1186","volume":"25","author":[{"given":"Geremew","family":"Tasew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro","family":"Abdella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birra","family":"Bejiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshetu","family":"Ejeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehageru","family":"Gizachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leuel","family":"Lisanwork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyiso","family":"Bati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Legesse","family":"Negash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Bonger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Festo","family":"Mazuguni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Mekuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokou Nouwame","family":"Alinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Shu-Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Ogwell Ouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiwot","family":"Moges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwossen","family":"Gebreyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Tollera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masresha","family":"Tessema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"11551_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijid.2020.10.011","volume":"101","author":"CC Lai","year":"2020","unstructured":"Lai CC, Wang JH, Hsueh PR. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review. Int J Infect Dis. 2020;101:314\u201322.","journal-title":"Int J Infect Dis"},{"issue":"10250","key":"11551_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","volume":"396","author":"M Poll\u00e1n","year":"2020","unstructured":"Poll\u00e1n M, P\u00e9rez-G\u00f3mez B, Pastor-Barriuso R, Oteo J, Hern\u00e1n MA, P\u00e9rez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535\u201344.","journal-title":"Lancet"},{"issue":"2","key":"11551_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jmii.2020.05.016","volume":"54","author":"CC Lai","year":"2021","unstructured":"Lai CC, Wang CY, Ko WC, Hsueh PR. In vitro diagnostics of coronavirus disease 2019: technologies and application. J Microbiol Immunol Infect. 2021;54(2):164\u201374.","journal-title":"J Microbiol Immunol Infect"},{"issue":"11","key":"11551_CR4","doi-asserted-by":"publisher","first-page":"e0241536","DOI":"10.1371\/journal.pone.0241536","volume":"15","author":"M Yanes-Lane","year":"2020","unstructured":"Yanes-Lane M, Winters N, Fregonese F, Bastos M, Perlman-Arrow S, Campbell JR, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS One. 2020;15(11):e0241536.","journal-title":"PLoS One"},{"issue":"14","key":"11551_CR5","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406.","journal-title":"JAMA"},{"issue":"2","key":"11551_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3201\/eid2702.201960","volume":"27","author":"M Shakiba","year":"2021","unstructured":"Shakiba M, Nazemipour M, Salari A, Mehrabian F, Nazari SSH, Rezvani SM, et al. Seroprevalence of SARS-CoV-2 in Guilan province, Iran, April 2020. Emerg Infect Dis. 2021;27(2):636\u20138.","journal-title":"Emerg Infect Dis"},{"key":"11551_CR7","unstructured":"H. Hangzhou Biotest Biotech Co., Ltd. (2020). RightSign\u2122 COVID-19 IgG\/IgM Rapid Test Cassette Package Insert. Document No. RS-COV-002. [Internet]. Available from: chromehttps:\/\/en.biotests.com.cn\/Upload\/file\/202204\/20220424145917_8686.pdf"},{"issue":"12","key":"11551_CR8","doi-asserted-by":"publisher","first-page":"e007179","DOI":"10.1136\/bmjgh-2021-007179","volume":"6","author":"GA Tessema","year":"2021","unstructured":"Tessema GA, Kinfu Y, Dachew BA, Tesema AG, Assefa Y, Alene KA, et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Glob Health. 2021;6(12):e007179.","journal-title":"BMJ Glob Health"},{"issue":"7855","key":"11551_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592(7855):616\u201322.","journal-title":"Nature"},{"issue":"6","key":"11551_CR10","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/S2666-5247(23)00006-X","volume":"4","author":"CKP Mok","year":"2023","unstructured":"Mok CKP, Chen C, Zhao S, Sun Y, Yiu K, Chan TO, et al. Omicron BA.1-specific T-cell responses in adults vaccinated with coronavac or BNT162b2 in Hong kong: an observational cohort study. Lancet Microbe. 2023;4(6):e418\u201330.","journal-title":"Lancet Microbe"},{"issue":"10250","key":"11551_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)31482-3","volume":"396","author":"I Eckerle","year":"2020","unstructured":"Eckerle I, Meyer B. SARS-CoV-2 seroprevalence in COVID-19 hotspots. Lancet. 2020;396(10250):514\u20135.","journal-title":"Lancet"},{"key":"11551_CR12","doi-asserted-by":"publisher","first-page":"102915","DOI":"10.1016\/j.ebiom.2020.102915","volume":"59","author":"S Fafi-Kremer","year":"2020","unstructured":"Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, et al. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in Eastern France. eBioMedicine. 2020;59:102915.","journal-title":"eBioMedicine"},{"issue":"1\u20132","key":"11551_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/ijmr.IJMR_3290_20","volume":"152","author":"MV Murhekar","year":"2020","unstructured":"Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, et al. Prevalence of SARS-CoV-2 infection in india: findings from the National serosurvey, May-June 2020. Indian J Med Res. 2020;152(1\u20132):48\u201360.","journal-title":"Indian J Med Res"},{"issue":"23","key":"11551_CR14","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1001\/jama.2020.8279","volume":"323","author":"N Sood","year":"2020","unstructured":"Sood N, Simon P, Ebner P, Eichner D, Reynolds J, Bendavid E, et al. Seroprevalence of SARS-CoV-2\u2013specific antibodies among adults in Los Angeles county, California, on April 10\u201311, 2020. JAMA. 2020;323(23):2425.","journal-title":"JAMA"},{"issue":"10279","key":"11551_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00238-5","volume":"397","author":"Z He","year":"2021","unstructured":"He Z, Ren L, Yang J, Guo L, Feng L, Ma C, et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet. 2021;397(10279):1075\u201384.","journal-title":"Lancet"},{"key":"11551_CR16","unstructured":"Federal Ministry of Health Ethiopia. COVID-19 Pandemic Preparedness and Response Monthly Bulletin. 2022 Jul."},{"key":"11551_CR17","unstructured":"Ethiopian Public Health. Institute (EPHI). COVID-19 situational report. 2022."},{"key":"11551_CR18","unstructured":"World Bank. COVID-19 testing capacity in low-income countries. 2022."},{"issue":"8","key":"11551_CR19","doi-asserted-by":"publisher","first-page":"e008793","DOI":"10.1136\/bmjgh-2022-008793","volume":"7","author":"HC Lewis","year":"2022","unstructured":"Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Health. 2022;7(8):e008793.","journal-title":"BMJ Glob Health"},{"issue":"5","key":"11551_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313791","volume":"20","author":"G Tasew","year":"2025","unstructured":"Tasew G, Abdella S, Bejiga B, Ayalew J, Tessema M, Bati F, et al. Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: results of the National population based survey, 2021. PLoS One. 2025;20(5): e0313791.","journal-title":"PLoS One"},{"issue":"247","key":"11551_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/01621459.1949.10483314","volume":"44","author":"L Kish","year":"1949","unstructured":"Kish L. A procedure for objective respondent selection within the household. J Am Stat Assoc. 1949;44(247):380\u20137.","journal-title":"J Am Stat Assoc"},{"key":"11551_CR22","unstructured":"World Health Organization (WHO). (. Toolkit for household surveys on health and nutrition. WHO; 2013."},{"key":"11551_CR23","unstructured":"Central Statistical Agency (CSA). Population projection of Ethiopia for all regions at woreda level from 2014\u20132017. Federal Democratic Republic of Ethiopia, Central Statistical Agency, Addis Ababa; 2017."},{"issue":"8","key":"11551_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200\u20134.","journal-title":"Nat Med"},{"issue":"1","key":"11551_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jinf.2020.03.012","volume":"81","author":"AT Xiao","year":"2020","unstructured":"Xiao AT, Gao C, Zhang S. Profile of specific antibodies to SARS-CoV-2: the first report. J Infect. 2020;81(1):147\u201378.","journal-title":"J Infect"},{"key":"11551_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00941-20","author":"A Bryan","year":"2020","unstructured":"Bryan A, Pepper G, Wener MH, Fink SL, Morishima C, Chaudhary A, et al. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. 2020. https:\/\/doi.org\/10.1128\/JCM.00941-20.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"11551_CR27","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/s41467-021-23233-6","volume":"12","author":"S Le Vu","year":"2021","unstructured":"Le Vu S, Jones G, Anna F, Rose T, Richard JB, Bernard-Stoecklin S, et al. Prevalence of SARS-CoV-2 antibodies in france: results from nationwide serological surveillance. Nat Commun. 2021;12(1):3025.","journal-title":"Nat Commun"},{"issue":"3","key":"11551_CR28","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(20)30544-1","volume":"9","author":"MV Murhekar","year":"2021","unstructured":"Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, et al. SARS-CoV-2 antibody Seroprevalence in india, August\u2013September, 2020: findings from the second nationwide household serosurvey. Lancet Glob Health. 2021;9(3):e257\u201366.","journal-title":"Lancet Glob Health"},{"issue":"10247","key":"11551_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","volume":"396","author":"S Stringhini","year":"2020","unstructured":"Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313\u20139.","journal-title":"Lancet"},{"key":"11551_CR30","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.108","volume":"44","author":"LP Borges","year":"2020","unstructured":"Borges LP, Martins AF, Melo MSD, Oliveira MGBD, Neto JMDR, D\u00f3sea MB, et al. Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in sergipe, Brazil. Rev Panam Salud Publica. 2020;44: 1.","journal-title":"Rev Panam Salud Publica"},{"issue":"4","key":"11551_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1473-3099(20)30858-6","volume":"21","author":"H Poustchi","year":"2021","unstructured":"Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2021;21(4):473\u201381.","journal-title":"Lancet Infect Dis"},{"key":"11551_CR32","doi-asserted-by":"publisher","first-page":"e29587","DOI":"10.2196\/29587","volume":"4","author":"H Majiya","year":"2023","unstructured":"Majiya H, Aliyu-Paiko M, Balogu VT, Musa DA, Salihu IM, Kawu AA, et al. Seroprevalence of SARS-CoV-2 in Niger state: pilot Cross-Sectional study. JMIRx Med. 2023;4:e29587\u201329587.","journal-title":"JMIRx Med"},{"key":"11551_CR33","doi-asserted-by":"publisher","first-page":"100292","DOI":"10.1016\/j.onehlt.2021.100292","volume":"13","author":"S Bellizzi","year":"2021","unstructured":"Bellizzi S, Alsawalha L, Sheikh Ali S, Sharkas G, Muthu N, Ghazo M, et al. A three-phase population based sero-epidemiological study: assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan. One Health. 2021;13:100292.","journal-title":"One Health"},{"issue":"3","key":"11551_CR34","doi-asserted-by":"publisher","first-page":"e1009413","DOI":"10.1371\/journal.ppat.1009413","volume":"17","author":"MR Gomaa","year":"2021","unstructured":"Gomaa MR, El Rifay AS, Shehata M, Kandeil A, Nabil Kamel M, Marouf MA, et al. Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. Fouchier RAM, editor PLOS Pathog. 2021;17(3):e1009413.","journal-title":"Fouchier RAM, editor. PLOS Pathog"},{"key":"11551_CR35","doi-asserted-by":"publisher","unstructured":"Wiens KE, Mawien PN, Rumunu J, Slater D, Jones FK, Moheed S et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study [Internet]. Public and Global Health; 2021 [cited 2025 Jun 20]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2021.03.08.21253009","DOI":"10.1101\/2021.03.08.21253009"},{"issue":"2","key":"11551_CR36","first-page":"308","volume":"15","author":"LF Pampa-Espinoza","year":"2022","unstructured":"Pampa-Espinoza LF, Padilla-Rojas C, Jim\u00e9nez-V\u00e1squez V, Silva I, D\u00edaz-Soria F, Villa-Galarce ZH. Reinfecciones Por SARS-CoV-2 Durante La Segunda Ola pand\u00e9mica En iquitos, Per\u00fa. Rev Cuerpo Med Hosp Nac Almanzor Aguinaga Asenjo. 2022;15(2):308\u20139.","journal-title":"Rev Cuerpo Med Hosp Nac Almanzor Aguinaga Asenjo"},{"key":"11551_CR37","doi-asserted-by":"crossref","unstructured":"Mattar S, Alvis-Guzman N, Garay E, Rivero R, Garc\u00eda A, Botero Y et al. SARS-CoV-2 Seroprevalence among adults in a tropical City of the Caribbean area, colombia: are we much closer to herd immunity than developed countries? In: Open Forum Infect Dis. 2020.","DOI":"10.1093\/ofid\/ofaa550"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11551-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11551-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11551-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:47:29Z","timestamp":1758804449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11551-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11551"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11551-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Scientific and Ethical Research Office (SERO) of the Ethiopian Public Health Institute (EPHI) (Protocol No. EPHI-IRB-439\u20132022, Meeting No. 107, Approval Date: 04 June 2022). The study was conducted in full compliance with the ethical principles of the Helsinki Declaration. Before enrollment, all potential participants were informed about the study\u2019s purpose, procedures, potential risks, and protections in their local language. Written informed consent was obtained from each participant for interviews, blood sample collection, and subsequent testing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1126"}}